Larcaviximab
Based on 1 Customer Validation
Larcaviximab (c4G7-N) is an IgG1 kappa chimeric monoclonal antibody against Ebola virus glycoprotein, which is applicable to studies related to Ebola virus infection.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 96.13%
- No. CAS: 1792982-56-9
- Peso molecular:144.96 kDa
-
Almacenamiento:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Virus
IC50 & Target
Zaire Ebola virus
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Gene ID
911829 [NCBI]
Accession
Conjugated
Unconjugated
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 kappa
Aplicación
ELISA, FACS, Functional assay
Chemical Information
-
No. CAS 1792982-56-9
-
Appearance Liquid
-
Peso molecular 144.96 kDa
-
Color Colorless to light yellow
-
SMILES
[Larcaviximab]
-
Synonyms
c4G7-N
-
Envío
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
Ficha de datos (256 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)